Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Index by author

June 1, 1992; Volume 33,Issue 6
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Abrams, Paul G.

    1. You have access
      Clinical Experience with Rhenium-186-Labeled Monoclonal Antibodies for Radioimmunotherapy: Results of Phase I Trials
      Hazel B. Breitz, Paul L. Weiden, J-L Vanderheyden, Janet W. Appelbaum, Michael J. Bjorn, Mehmet F. Fer, Sandra B. Wolf, Barbara A. Ratliff, Christine A. Seiler, Debbie C. Foisie, Darrell R. Fisher, Robert W. Schroff, Alan R. Fritzberg and Paul G. Abrams
      Journal of Nuclear Medicine June 1, 1992, 33 (6) 1099-1109;
  2. Aden, Michael D.

    1. You have access
      Radioiodine-131 Therapy for Well-Differentiated Thyroid Cancer—A Quantitative Radiation Dosimetric Approach: Outcome and Validation in 85 Patients
      Harry R. Maxon, Emanuela E. Englaro, Stephen R. Thomas, Vicki S. Hertzberg, Jerry D. Hinnefeld, L.S. Chen, H. Smith, Dwight Cummings and Michael D. Aden
      Journal of Nuclear Medicine June 1, 1992, 33 (6) 1132-1136;
  3. Appelbaum, Janet W.

    1. You have access
      Clinical Experience with Rhenium-186-Labeled Monoclonal Antibodies for Radioimmunotherapy: Results of Phase I Trials
      Hazel B. Breitz, Paul L. Weiden, J-L Vanderheyden, Janet W. Appelbaum, Michael J. Bjorn, Mehmet F. Fer, Sandra B. Wolf, Barbara A. Ratliff, Christine A. Seiler, Debbie C. Foisie, Darrell R. Fisher, Robert W. Schroff, Alan R. Fritzberg and Paul G. Abrams
      Journal of Nuclear Medicine June 1, 1992, 33 (6) 1099-1109;
  4. Bacharach, Stephen L.

    1. You have access
      Misalignment Between PET Transmission and Emission Scans: Its Effect on Myocardial Imaging
      Miles E. McCord, Stephen L. Bacharach, Robert O. Bonow, Vaskin Dilsizian, Alberto Cuocolo and Nanette Freedman
      Journal of Nuclear Medicine June 1, 1992, 33 (6) 1209-1214;
  5. Besser, G.M.

    1. You have access
      A Scintigraphic Comparison of Iodine-123-Metaiodobenzylguanidine and an Iodine-Labeled Somatostatin Analog (Tyr-3-Octreotide) in Metastatic Carcinoid Tumors
      J. Bomanji, E. Ur, S. Mather, J. Moyes, D. Ellison, A. Grossman, K.E. Britton and G.M. Besser
      Journal of Nuclear Medicine June 1, 1992, 33 (6) 1121-1124;
  6. Bice, Alden

    1. You have access
      Effect of Differential Tracer Washout During SPECT Acquisition
      Bernard D. Bok and Alden Bice
      Journal of Nuclear Medicine June 1, 1992, 33 (6) 1251;
  7. Bjorn, Michael J.

    1. You have access
      Clinical Experience with Rhenium-186-Labeled Monoclonal Antibodies for Radioimmunotherapy: Results of Phase I Trials
      Hazel B. Breitz, Paul L. Weiden, J-L Vanderheyden, Janet W. Appelbaum, Michael J. Bjorn, Mehmet F. Fer, Sandra B. Wolf, Barbara A. Ratliff, Christine A. Seiler, Debbie C. Foisie, Darrell R. Fisher, Robert W. Schroff, Alan R. Fritzberg and Paul G. Abrams
      Journal of Nuclear Medicine June 1, 1992, 33 (6) 1099-1109;
  8. Bok, Bernard D.

    1. You have access
      Effect of Differential Tracer Washout During SPECT Acquisition
      Bernard D. Bok and Alden Bice
      Journal of Nuclear Medicine June 1, 1992, 33 (6) 1251;
  9. Bomanji, J.

    1. You have access
      A Scintigraphic Comparison of Iodine-123-Metaiodobenzylguanidine and an Iodine-Labeled Somatostatin Analog (Tyr-3-Octreotide) in Metastatic Carcinoid Tumors
      J. Bomanji, E. Ur, S. Mather, J. Moyes, D. Ellison, A. Grossman, K.E. Britton and G.M. Besser
      Journal of Nuclear Medicine June 1, 1992, 33 (6) 1121-1124;
  10. Bonow, Robert O.

    1. You have access
      Misalignment Between PET Transmission and Emission Scans: Its Effect on Myocardial Imaging
      Miles E. McCord, Stephen L. Bacharach, Robert O. Bonow, Vaskin Dilsizian, Alberto Cuocolo and Nanette Freedman
      Journal of Nuclear Medicine June 1, 1992, 33 (6) 1209-1214;
« Previous (Pages : 1 2 3 4 5 6 ... 16) Next »
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine
Vol. 33, Issue 6
June 1, 1992
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire